Article info

Download PDFPDF
Letters
Neonatal drug trials: impact of EU and US paediatric regulations

Authors

  • Claudia Pansieri Service de Pharmacologie Pédiatrique, AP-HP, Hôpital Robert Debré, Paris, France Laboratory for Mother and Child Health, Department of Public Health, IRCCS Istituto di Ricerche Farmacologiche ‘Mario Negri’, Milan, Italy PubMed articlesGoogle scholar articles
  • Maurizio Bonati Laboratory for Mother and Child Health, Department of Public Health, IRCCS Istituto di Ricerche Farmacologiche ‘Mario Negri’, Milan, Italy PubMed articlesGoogle scholar articles
  • Imti Choonara Academic Division of Child Health, Derbyshire Children's Hospital, University of Nottingham, Derby, UK PubMed articlesGoogle scholar articles
  • Evelyne Jacqz-Aigrain Service de Pharmacologie Pédiatrique, AP-HP, Hôpital Robert Debré, Paris, France Université Paris Diderot, Sorbonne Paris Cité, Paris, France INSERM, CIC1426, Hôpital Robert Debré, Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Evelyne Jacqz-Aigrain, Department of Paediatric Pharmacology and Pharmacogénétics, Hôpital Robert Debré, 48 boulevard Serurier, Paris 75019, France; evelyne.jacqz-aigrain{at}rdb.aphp.fr
View Full Text

Citation

Pansieri C, Bonati M, Choonara I, et al
Neonatal drug trials: impact of EU and US paediatric regulations

Publication history

  • Accepted April 7, 2014
  • First published May 3, 2014.
Online issue publication 
March 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.